tradingkey.logo
tradingkey.logo
Search

Pharming Group NV

PHAR
Add to Watchlist
10.210USD
-0.540-5.02%
Close 07-31 16:00ETQuotes delayed by 15 min
0.00Market Cap
--P/E TTM

Earnings Forecast

Currency: USD Updated:
Previous score
0.00
Change
0

Analyst Rating

Based on 6 analysts
Strong Buy
Current Rating
2.093
Target Price
-82.57%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

160
Total
6
Median
9
Average
Company name
Ratings
Analysts
Pharming Group NV
PHAR
6
Amgen Inc
AMGN
38
Biogen Inc
BIIB
38
Eli Lilly and Co
LLY
34
AbbVie Inc
ABBV
33
Pfizer Inc
PFE
32
1
2
3
...
32

Support & Resistance

Relevant data have not been disclosed by the company yet.

FAQs

What is the analyst rating for Pharming Group NV?

Based on the ratings of Pharming Group NV's stock from 6 analysts, most analysts support a STRONG BUY trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as STRONG BUY. Please note that this is not trading advice. You still need to conduct your own analysis.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.